Evidence map›Paper›PMID 42784634›Full record

ArticlePLoS pathogens2026

Functional divergence of the Bhanja virus NSs protein modulates interferon antagonism and viral fitness across divergent lineages.

Andrew T Clarke, Kelsey Davies, Mazigh Fares, Agnieszka M Szemiel, Diogo Correa Mendonca, Karen Kerr, Vanessa Herder, Lesley Bell-Sakyi, Brian J Willett, Arvind H Patel and 2 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrew T ClarkeMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Kelsey DaviesMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Mazigh FaresMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Agnieszka M SzemielMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Diogo Correa MendoncaCVR Translational Hub, MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Karen KerrCVR Translational Hub, MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Vanessa HerderCVR Translational Hub, MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Lesley Bell-SakyiDepartment of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Brian J WillettMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Arvind H PatelCVR Translational Hub, MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID https://orcid.org/0000-0003-4600-2047
Alain KohlMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Benjamin BrennanMedical Research Council-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.ORCID https://orcid.org/0000-0003-4707-726X

Funding

Wellcome Trust
6 · The paper itself

Abstract

Bhanja virus (BHAV) is a tick-borne bandavirus (Family Phenuiviridae) with a broad geographic distribution and documented neuroinvasive capacity, yet its molecular biology remains poorly understood. Within the genus Bandavirus, the non-structural protein NSs functions as the primary antagonist of innate immune responses, although mechanistic details for BHAV remain unknown. We established a reverse genetics platform for BHAV by combining virion RNA sequencing with terminal untranslated region mapping, enabling generation of recombinant viruses and systematic investigation of viral determinants. Using this system, we characterized recombinant BHAV replication in mammalian and arthropod cell lines and demonstrated that interferon competence is a critical determinant of viral replication in mammalian cells. Notably, we observed substantial amino acid divergence within the NSs protein across geographically distinct BHAV isolates, despite higher conservation of other viral proteins. To investigate the functional significance of this variation, we generated recombinant viruses expressing heterologous NSs proteins from African and European isolates. Viruses expressing NSs from ibAr2709 or R1819 isolates exhibited enhanced capacity to suppress interferon-beta induction compared to the prototype IG690 strain, correlating with increased viral protein accumulation in interferon-competent cells. Mechanistic studies revealed that BHAV NSs proteins inhibit interferon induction upstream of IRF3, with ibAr2709 and R1819 NSs showing selective inhibition of TBK1 phosphorylation. However, unlike highly pathogenic bandaviruses such as severe fever with thrombocytopenia syndrome virus (SFTSV), BHAV NSs proteins exhibit comparatively weak antagonism of downstream interferon signalling. In vivo studies using interferon alpha/beta receptor-deficient mice demonstrated that NSs sequence variation influences viral replication in splenic tissue without substantially altering disease phenotype. Together, these findings establish BHAV reverse genetics tools for future investigation and reveal how naturally-occurring NSs divergence modulates innate immune antagonism and viral fitness while maintaining an overall attenuated disease phenotype.

Indexed as

Interferon-betaViral Nonstructural ProteinsAnimalsCell LineHumansImmunity, InnateInterferon Regulatory Factor-3PicornaviralesVirus ReplicationInterferon-betaInterferon Regulatory Factor-3Viral Nonstructural Proteins

Identifiers

PMID42784634
PMCPMC13626475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.